Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Dina Segal"'
Autor:
Denkberg Galit, Oryan Makler, Gideon Rechavi, Ninette Amariglio, Kfir Oved, Yoram Reiter, Hila Novak, Omer Ziv, Chen Gefen-Dor, Sinik Keren, Roy Noy, Dina Segal, Jasmine Jacob-Hirsch
Publikováno v:
The Journal of Immunology. 178:2307-2317
CTLs act as the effector arm of the cell-mediated immune system to kill undesirable cells. Two processes regulate these effector cells to prevent self reactivity: a thymic selection process that eliminates autoreactive clones and a multistage activat
Publikováno v:
Cancer Immunology, Immunotherapy. 54:867-879
Soluble forms of human MHC class I HLA-A2 were produced in which the peptide binding groove was uniformly occupied by a single tumor or viral-derived peptides attached via a covalent flexible peptide linker to the N terminus of a single-chain beta-2-
Autor:
Ella Trubniykov, Galit Denkberg, Cyril J. Cohen, Yael S. Schiffenbauer, Yoram Reiter, Dina Segal, Gideon Berke
Publikováno v:
Journal of Immunological Methods. 277:39-52
The recent advent of peptide–MHC tetramers has provided a new and effective tool for studying antigen-specific T cell populations through monitoring tetramer binding to T cells by flow cytometry. Yet information regarding T cell activation induced
Publikováno v:
The Journal of Immunology. 169:2988-2996
The MHC class I-restricted CD8 CTL effector arm of the adaptive immune response is uniquely equipped to recognize tumor cells as foreign and consequently initiates the cascade of events resulting in their destruction. However, tumors have developed s
Publikováno v:
International Journal of Cancer. 94:864-872
The MDR1 gene product P-glycoprotein (Pgp) plays a key role in multidrug resistance of cancer cells. Pgp is an ATP-driven efflux pump that extrudes a variety of dissimilar hydrophobic cytotoxic compounds. P-glycoprotein overexpression results in mult
Publikováno v:
European Journal of Immunology. 30:3522-3532
Soluble recombinant MHC-peptide complexes are valuable tools for molecular characterization of immune responses as well as for other functional and structural studies. In this study, soluble recombinant single-chain human MHC (scMHC)-peptide complexe
Publikováno v:
International journal of cancer. 120(2)
Epidermal growth factor receptor (EGFR) is highly overexpressed in many tumor types. We present a new fusion molecule that can target solid tumors that express EGFR. The fusion molecule combines the advantage(s) of the well-established tumor targetin
Publikováno v:
Cholinergic Mechanisms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4a7d9af384d63cdddb4eab5d31926f8
https://doi.org/10.3109/9780203493878-98
https://doi.org/10.3109/9780203493878-98
Autor:
Roy Noy, Avital Lev, Peter Walden, Yoram Reiter, Dina Segal, Dietmar Zehn, Hila Novak, Kfir Oved
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America. 101(24)
A cancer immunotherapy strategy is described herein that combines the advantage of the well established tumor targeting capabilities of high-affinity recombinant fragments of Abs with the known efficient, specific, and potent killing ability of CD8 T